Literature DB >> 23712303

Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection.

Nathan K Ho1, Aleah C Henry, Kathene Johnson-Henry, Philip M Sherman.   

Abstract

Enterohemorrhagic Escherichia coli serotype O157:H7 is a food- and waterborne pathogen that causes significant morbidity and mortality in both developing and industrialized nations. The present review focuses on the history, epidemiology and evolution of the pathogen; provides a mechanistic overview of major virulence factors (including Shiga toxins, locus of enterocyte effacement pathogenicity island and pO157 plasmid); discusses host immune responses to infection; considers available animal models; and provides an overview of current and potential future management considerations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23712303      PMCID: PMC3735731          DOI: 10.1155/2013/138673

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  55 in total

1.  Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells.

Authors:  Irina Maluykova; Oksana Gutsal; Marina Laiko; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Biochim Biophys Acta       Date:  2008-02-20

2.  Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin.

Authors:  M S Islam; W H Stimson
Journal:  J Clin Lab Immunol       Date:  1990-09

Review 3.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

Review 4.  The machinery of Nod-like receptors: refining the paths to immunity and cell death.

Authors:  Maya Saleh
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

5.  Eculizumab in severe Shiga-toxin-associated HUS.

Authors:  Anne-Laure Lapeyraque; Michal Malina; Véronique Fremeaux-Bacchi; Tobias Boppel; Michael Kirschfink; Mehdi Oualha; François Proulx; Marie-José Clermont; Françoise Le Deist; Patrick Niaudet; Franz Schaefer
Journal:  N Engl J Med       Date:  2011-05-25       Impact factor: 91.245

6.  Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7.

Authors:  P Feng; K A Lampel; H Karch; T S Whittam
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

7.  Enteric pathogens and gut function: Role of cytokines and STATs.

Authors:  Terez Shea-Donohue; Alessio Fasano; Allen Smith; Aiping Zhao
Journal:  Gut Microbes       Date:  2010-05-12

8.  Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial.

Authors:  Howard Trachtman; Avital Cnaan; Erica Christen; Kathleen Gibbs; Sanyi Zhao; David W K Acheson; Robert Weiss; Frederick J Kaskel; Adrian Spitzer; Gladys H Hirschman
Journal:  JAMA       Date:  2003-09-10       Impact factor: 56.272

Review 9.  Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.

Authors:  Antonio Serna; Edgar C Boedeker
Journal:  Curr Opin Gastroenterol       Date:  2008-01       Impact factor: 3.287

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  10 in total

1.  IRTKS (BAIAP2L1) Elongates Epithelial Microvilli Using EPS8-Dependent and Independent Mechanisms.

Authors:  Meagan M Postema; Nathan E Grega-Larson; Abigail C Neininger; Matthew J Tyska
Journal:  Curr Biol       Date:  2018-09-06       Impact factor: 10.834

Review 2.  Strategies for Biofilm Inhibition and Virulence Attenuation of Foodborne Pathogen-Escherichia coli O157:H7.

Authors:  Sandra Folarin Oloketuyi; Fazlurrahman Khan
Journal:  Curr Microbiol       Date:  2017-07-25       Impact factor: 2.188

3.  Dps Protects Enterohemorrhagic Escherichia coli against Acid-Induced Antimicrobial Peptide Killing.

Authors:  Tracy Lackraj; Sarah Birstonas; Michele Kacori; Debora Barnett Foster
Journal:  J Bacteriol       Date:  2020-05-11       Impact factor: 3.490

4.  Brush Border Destruction by Enterohemorrhagic Escherichia coli (EHEC): New Insights From Organoid Culture.

Authors:  Matthew J Tyska
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-11-25

5.  Transcriptional Activator GmrA, Encoded in Genomic Island OI-29, Controls the Motility of Enterohemorrhagic Escherichia coli O157:H7.

Authors:  Bin Yang; Shaomeng Wang; Jianxiao Huang; Zhiqiu Yin; Lingyan Jiang; Wenqi Hou; Xiaomin Li; Lu Feng
Journal:  Front Microbiol       Date:  2018-02-22       Impact factor: 5.640

6.  Computational Analysis of Host-Pathogen Protein Interactions between Humans and Different Strains of Enterohemorrhagic Escherichia coli.

Authors:  Tungadri Bose; K V Venkatesh; Sharmila S Mande
Journal:  Front Cell Infect Microbiol       Date:  2017-04-19       Impact factor: 5.293

7.  Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines.

Authors:  Sára Kellnerová; Sneha Chatterjee; Rafael Bayarri-Olmos; Louise Justesen; Heribert Talasz; Wilfried Posch; Samyr Kenno; Peter Garred; Dorothea Orth-Höller; Marco Grasse; Reinhard Würzner
Journal:  Toxins (Basel)       Date:  2020-12-24       Impact factor: 5.075

8.  Virulence-related O islands in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Lingyan Jiang; Wen Yang; Xinlei Jiang; Ting Yao; Lu Wang; Bin Yang
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 9.  Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Hongmin Sun; Min Wang; Yutao Liu; Pan Wu; Ting Yao; Wen Yang; Qian Yang; Jun Yan; Bin Yang
Journal:  Gut Microbes       Date:  2022 Jan-Dec

10.  Antibodies Directed against Shiga-Toxin Producing Escherichia coli Serotype O103 Type III Secreted Proteins Block Adherence of Heterologous STEC Serotypes to HEp-2 Cells.

Authors:  Taseen S Desin; Hugh G Townsend; Andrew A Potter
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.